Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
San Gabriel Clinical Research
mi
from
Georgetown, TX
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
San Gabriel Clinical Research
mi
from
Georgetown, TX
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
SHS Clinical Research Group
mi
from
Toms River, NJ
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
SHS Clinical Research Group
mi
from
Toms River, NJ
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Suncoast Research Group, LLC
mi
from
Miami, FL
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Suncoast Research Group, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
University Diabetes and Endocrine Consultants
mi
from
Chattanooga, TN
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
University Diabetes and Endocrine Consultants
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Univ of Hawaii
mi
from
Honolulu, HI
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Univ of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Valley Endocrine, Fresno
mi
from
Fresno, CA
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Valley Endocrine, Fresno
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Victorium Clinical Research
mi
from
San Antonio, TX
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Victorium Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
mi
from
Athens,
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
mi
from
Athens,
Click here to add this to my saved trials
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Office:Alwine,Lk
mi
from
Downingtown, PA
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Office:Alwine,Lk
mi
from
Downingtown, PA
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Buena Park, CA
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Buena Park, CA
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Huntington Park, CA
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Huntington Park, CA
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Westlake Village, CA
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Westlake Village, CA
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Jupiter, FL
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Jupiter, FL
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
New Port Richey, FL
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Topeka, KA
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Madisonville, KY
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Madisonville, KY
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Las Vegas, NV
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Rapid City, SD
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Rapid City, SD
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
San Antonio, TX
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Norfolk, VA
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/24/2018
Research Site
mi
from
Aschaffenburg,
A Study for Participants With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/24/2018
Research Site
mi
from
Aschaffenburg,
Click here to add this to my saved trials
Prospective Assessment in Newborns for Diabetes Autoimmunity
1. Prospective Studies in Infants of the Immunopathogenesis of Type 1 Diabetes 2. Consortium for Identification of Environmental Triggers of Type 1 Diabetes: MCG/UF Clinical Center 3. Identification of Serum Protein Markers for Type 1 Diabetes Using Mass-Spectrometry Techniques 4. Validation of Microarray-Based Biomarkers for Type 1 Diabetes 5. Development of Microarray-Based Biomarkers for Type 1 Diabetes 6. Proteomic Changes/Progression of Human Type 1 Diabetes 7. Identification and Validation of Serum Biomarkers for T1D
Status: Enrolling
Updated:  3/26/2018
University of Florida
mi
from
Gainesville, FL
Prospective Assessment in Newborns for Diabetes Autoimmunity
1. Prospective Studies in Infants of the Immunopathogenesis of Type 1 Diabetes 2. Consortium for Identification of Environmental Triggers of Type 1 Diabetes: MCG/UF Clinical Center 3. Identification of Serum Protein Markers for Type 1 Diabetes Using Mass-Spectrometry Techniques 4. Validation of Microarray-Based Biomarkers for Type 1 Diabetes 5. Development of Microarray-Based Biomarkers for Type 1 Diabetes 6. Proteomic Changes/Progression of Human Type 1 Diabetes 7. Identification and Validation of Serum Biomarkers for T1D
Status: Enrolling
Updated: 3/26/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Prospective Assessment in Newborns for Diabetes Autoimmunity
1. Prospective Studies in Infants of the Immunopathogenesis of Type 1 Diabetes 2. Consortium for Identification of Environmental Triggers of Type 1 Diabetes: MCG/UF Clinical Center 3. Identification of Serum Protein Markers for Type 1 Diabetes Using Mass-Spectrometry Techniques 4. Validation of Microarray-Based Biomarkers for Type 1 Diabetes 5. Development of Microarray-Based Biomarkers for Type 1 Diabetes 6. Proteomic Changes/Progression of Human Type 1 Diabetes 7. Identification and Validation of Serum Biomarkers for T1D
Status: Enrolling
Updated:  3/26/2018
Medical University of South Carolina
mi
from
Charleston, SC
Prospective Assessment in Newborns for Diabetes Autoimmunity
1. Prospective Studies in Infants of the Immunopathogenesis of Type 1 Diabetes 2. Consortium for Identification of Environmental Triggers of Type 1 Diabetes: MCG/UF Clinical Center 3. Identification of Serum Protein Markers for Type 1 Diabetes Using Mass-Spectrometry Techniques 4. Validation of Microarray-Based Biomarkers for Type 1 Diabetes 5. Development of Microarray-Based Biomarkers for Type 1 Diabetes 6. Proteomic Changes/Progression of Human Type 1 Diabetes 7. Identification and Validation of Serum Biomarkers for T1D
Status: Enrolling
Updated: 3/26/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Prospective Assessment in Newborns for Diabetes Autoimmunity
1. Prospective Studies in Infants of the Immunopathogenesis of Type 1 Diabetes 2. Consortium for Identification of Environmental Triggers of Type 1 Diabetes: MCG/UF Clinical Center 3. Identification of Serum Protein Markers for Type 1 Diabetes Using Mass-Spectrometry Techniques 4. Validation of Microarray-Based Biomarkers for Type 1 Diabetes 5. Development of Microarray-Based Biomarkers for Type 1 Diabetes 6. Proteomic Changes/Progression of Human Type 1 Diabetes 7. Identification and Validation of Serum Biomarkers for T1D
Status: Enrolling
Updated:  3/26/2018
University of South Carolina
mi
from
Columbia, SC
Prospective Assessment in Newborns for Diabetes Autoimmunity
1. Prospective Studies in Infants of the Immunopathogenesis of Type 1 Diabetes 2. Consortium for Identification of Environmental Triggers of Type 1 Diabetes: MCG/UF Clinical Center 3. Identification of Serum Protein Markers for Type 1 Diabetes Using Mass-Spectrometry Techniques 4. Validation of Microarray-Based Biomarkers for Type 1 Diabetes 5. Development of Microarray-Based Biomarkers for Type 1 Diabetes 6. Proteomic Changes/Progression of Human Type 1 Diabetes 7. Identification and Validation of Serum Biomarkers for T1D
Status: Enrolling
Updated: 3/26/2018
University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes
Effectiveness of a Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes: Rationale and Study Protocol - Pilot Study
Status: Enrolling
Updated:  3/26/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes
Effectiveness of a Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes: Rationale and Study Protocol - Pilot Study
Status: Enrolling
Updated: 3/26/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes
Effectiveness of a Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes: Rationale and Study Protocol - Pilot Study
Status: Enrolling
Updated:  3/26/2018
Reading Health System
mi
from
Reading, PA
Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes
Effectiveness of a Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes: Rationale and Study Protocol - Pilot Study
Status: Enrolling
Updated: 3/26/2018
Reading Health System
mi
from
Reading, PA
Click here to add this to my saved trials
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Status: Enrolling
Updated:  3/27/2018
Veterans Affairs Medical Center
mi
from
Omaha, NE
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Status: Enrolling
Updated: 3/27/2018
Veterans Affairs Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Status: Enrolling
Updated:  3/27/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Status: Enrolling
Updated: 3/27/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Extended Arm Physician, Inc.
mi
from
Montgomery, AL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Extended Arm Physician, Inc.
mi
from
Montgomery, AL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
North American Research Institute
mi
from
Azusa, CA
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
North American Research Institute
mi
from
Azusa, CA
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Renal Consultants Medical Group
mi
from
Granada Hills, CA
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Renal Consultants Medical Group
mi
from
Granada Hills, CA
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Marin Endocrine Associates
mi
from
Greenbrae, CA
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Marin Endocrine Associates
mi
from
Greenbrae, CA
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Academic Medical Research Institute
mi
from
Los Angeles, CA
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Academic Medical Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Sutter Gould Medical Foundation
mi
from
Modesto, CA
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Sutter Gould Medical Foundation
mi
from
Modesto, CA
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Infosphere
mi
from
West Hills, CA
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Infosphere
mi
from
West Hills, CA
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Chase Medical Research, LLC
mi
from
Waterbury, CT
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Chase Medical Research, LLC
mi
from
Waterbury, CT
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
The Center for Diabetes and Endocrine Care
mi
from
Hollywood, FL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
The Center for Diabetes and Endocrine Care
mi
from
Hollywood, FL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
East Coast Clinical Research
mi
from
Jacksonville, FL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
East Coast Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Ocean Blue Medical Research Center, Inc.
mi
from
Miami Springs, FL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Ocean Blue Medical Research Center, Inc.
mi
from
Miami Springs, FL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
San Marcus Research Clinic
mi
from
Miami, FL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
San Marcus Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Pharmax Research Clinic
mi
from
Miami, FL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Pharmax Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Avanced Medical and Pain Mangement Research Clinic (AMPM)
mi
from
Miami, FL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Avanced Medical and Pain Mangement Research Clinic (AMPM)
mi
from
Miami, FL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Baptist Diabetes Association
mi
from
Miami, FL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Baptist Diabetes Association
mi
from
Miami, FL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Discovery Medical Research Group
mi
from
Ocala, FL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Discovery Medical Research Group
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Suncoast Clinical Research
mi
from
Palm Harbor, FL
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Suncoast Clinical Research
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
University of Hawaii Clinical Research
mi
from
Honolulu, HI
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
University of Hawaii Clinical Research
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated:  3/27/2018
Boise Kidney & Hypertension Institute, PLLC
mi
from
Caldwell, ID
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
Status: Enrolling
Updated: 3/27/2018
Boise Kidney & Hypertension Institute, PLLC
mi
from
Caldwell, ID
Click here to add this to my saved trials